<SEC-DOCUMENT>0000950170-24-052877.txt : 20240503
<SEC-HEADER>0000950170-24-052877.hdr.sgml : 20240503
<ACCEPTANCE-DATETIME>20240503160522
ACCESSION NUMBER:		0000950170-24-052877
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20240419
FILED AS OF DATE:		20240503
DATE AS OF CHANGE:		20240503

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			ATAI Life Sciences AG
		CENTRAL INDEX KEY:			0001776242
		ORGANIZATION NAME:           	
		STATE OF INCORPORATION:			2M
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-31187
		FILM NUMBER:		24912971

	BUSINESS ADDRESS:	
		STREET 1:		KRAUSENSTRASSE 9-10
		CITY:			BERLIN
		STATE:			2M
		ZIP:			10117
		BUSINESS PHONE:		4917632963813

	MAIL ADDRESS:	
		STREET 1:		KRAUSENSTRASSE 9-10
		CITY:			BERLIN
		STATE:			2M
		ZIP:			10117

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			ATAI Life Sciences N.V.
		CENTRAL INDEX KEY:			0001840904
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-31187
		FILM NUMBER:		24912972

	BUSINESS ADDRESS:	
		STREET 1:		WALLSTRASSE 16
		CITY:			BERLIN
		STATE:			2M
		ZIP:			10179
		BUSINESS PHONE:		(617)-699-5876

	MAIL ADDRESS:	
		STREET 1:		524 BROADWAY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER NAME:	
		FORMER CONFORMED NAME:	ATAI Life Sciences B.V.
		DATE OF NAME CHANGE:	20210115

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IntelGenx Technologies Corp.
		CENTRAL INDEX KEY:			0001098880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				870638336
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		6420 ABRAMS
		CITY:			SAINT LAURENT
		STATE:			A8
		ZIP:			H4S 1Y2
		BUSINESS PHONE:		514-331-7440

	MAIL ADDRESS:	
		STREET 1:		6420 ABRAMS
		CITY:			SAINT LAURENT
		STATE:			A8
		ZIP:			H4S 1Y2

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIG FLASH CORP
		DATE OF NAME CHANGE:	19991112
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2024-04-19</periodOfReport>

    <issuer>
        <issuerCik>0001098880</issuerCik>
        <issuerName>IntelGenx Technologies Corp.</issuerName>
        <issuerTradingSymbol>IGXT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001840904</rptOwnerCik>
            <rptOwnerName>ATAI Life Sciences N.V.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>WALLSTRABE 16</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>BERLIN</rptOwnerCity>
            <rptOwnerState>2M</rptOwnerState>
            <rptOwnerZipCode>10179</rptOwnerZipCode>
            <rptOwnerStateDescription>GERMANY</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>false</isDirector>
            <isOfficer>false</isOfficer>
            <isTenPercentOwner>true</isTenPercentOwner>
            <isOther>false</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001776242</rptOwnerCik>
            <rptOwnerName>ATAI Life Sciences AG</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>WALLSTRABE 16</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>BERLIN</rptOwnerCity>
            <rptOwnerState>2M</rptOwnerState>
            <rptOwnerZipCode>10179</rptOwnerZipCode>
            <rptOwnerStateDescription>GERMANY</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>false</isDirector>
            <isOfficer>false</isOfficer>
            <isTenPercentOwner>true</isTenPercentOwner>
            <isOther>false</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>false</aff10b5One>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Convertible Notes</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.185</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2024-04-19</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>J</transactionCode>
                <equitySwapInvolved>false</equitySwapInvolved>
                <footnoteId id="F1"/>
            </transactionCoding>
            <transactionAmounts>
                <transactionTotalValue>
                    <value>1000000</value>
                </transactionTotalValue>
                <transactionPricePerShare>
                    <footnoteId id="F1"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2024-04-19</value>
            </exerciseDate>
            <expirationDate>
                <value>2026-02-01</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>5405405</value>
                    <footnoteId id="F1"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <valueOwnedFollowingTransaction>
                    <value>10500000</value>
                </valueOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>By ATAI Life Sciences AG</value>
                    <footnoteId id="F2"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">On April 19, 2024, pursuant to the Third Amended and Restated Loan Agreement, ATAI AG provided to IntelGenX Corp. an additional term loan in an amount equal to $1,000,000, which is convertible to shares of Common Stock at a price of $0.185 per share. Any accrued interest outstanding under the loan may be converted into shares of Common Stock at the five day volume weighted average price of the shares, less the maximum permitted discount under certain applicable rules, ending on the day that is the second business day before the day the interest becomes due and payable.</footnote>
        <footnote id="F2">Reflects securities held of record by ATAI AG, which is a wholly owned subsidiary of ATAI Life Sciences N.V., and as a result, ATAI Life Sciences N.V. may be deemed to share beneficial ownership over the securities reported herein.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>ATAI Life Sciences N.V., By: /s/ Florian Brand, Chief Executive Officer</signatureName>
        <signatureDate>2024-05-03</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>ATAI Life Sciences AG, By: /s/ Florian Brand, Chief Executive Officer</signatureName>
        <signatureDate>2024-05-03</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
